Identifying implications of thrombolysis for stroke rehabilitation: Knowledge gaps in current research

References

• Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S. Acute ischemic stroke update. Pharmacotherapy 2010;30:493–514.
   PubMed Web of Science ®Google Scholar
• National Stroke Foundation. Facts figures and statistics. 2010 [23 August 2010]; Available from: www.strokefoundation.com.au/facts-figures-and-stats
   Google Scholar
• World Health Organisation. Global burden of stroke. In The Atlas of Heart Disease and Stroke. 2004 [accessed 15 December 2011]; Available from: www.who.int/cardiovascular_disease/en/cvd_atlas_15_burden_stroke.pdf
   Google Scholar
• Williams M, Patil S, Toledo EG, Vannemreddy P. Management of acute ischemic stroke: current status of pharmacological and mechanical endovascular methods. Neurol Res 2009;31:807–815.
   PubMed Web of Science ®Google Scholar
• Donnan GA, Davis SM, Parsons MW, Ma H, Dewey HM, Howells DW. How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol 2011;7:400–409.
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009;4:CD000213.
   PubMedGoogle Scholar
• Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864–870.
   PubMed Web of Science ®Google Scholar
• van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
   PubMed Web of Science ®Google Scholar
• Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J 1965;14:61–65.
   PubMedGoogle Scholar
• Barber PA, Parsons MW, Desmond PM, Bennett DA, Donnan GA, Tress BM, Davis SM. The use of PWI and DWI measures in the design of “proof-of-concept” stroke trials. J Neuroimaging 2004;14:123–132.
   PubMed Web of Science ®Google Scholar
• Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612–1623.
   PubMed Web of Science ®Google Scholar
• Stemer A, Lyden P. Evolution of the thrombolytic treatment window for acute ischemic stroke. Curr Neurol Neurosci Rep 2010;10:29–33.
   PubMed Web of Science ®Google Scholar
• National Institute of Neurological Disorders and Stroke. Tissue plasminogen activator for acute ischemic stroke. The New England Journal of Medicine. 1995;333:1581–1587.
   PubMed Web of Science ®Google Scholar
• Fagan SC. Stroke: Measuring disease-free life after thrombolysis. Nat Rev Neurol 2010;6:361–362.
   PubMed Web of Science ®Google Scholar
• Davis SM, Donnan GA, Butcher KS, Parsons M. Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol 2005;18:47–52.
   PubMed Web of Science ®Google Scholar
• Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, et al.; EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309.
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). The Lancet 2008;352:1245–1251.
   Web of Science ®Google Scholar
• Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695–1703.
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C, Von Krummer R, Davalos A, Meier C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intraveneous alteplase in acute ischemic stroke (ECASS II). The Lancet 1998;352:1245–1251.
   PubMed Web of Science ®Google Scholar
• Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019–2026.
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–1025.
   PubMed Web of Science ®Google Scholar
• Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 2000;31:811–816.
   PubMed Web of Science ®Google Scholar
• Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145–1150.
   PubMed Web of Science ®Google Scholar
• Nakagawara J, Minematsu K, Okada Y, Tanahashi N, Nagahiro S, Mori E, Shinohara Y, Yamaguchi T; J-MARS Investigators. Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS). Stroke 2010;41:1984–1989.
   PubMed Web of Science ®Google Scholar
• Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, et al.; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275–282.
   PubMed Web of Science ®Google Scholar
• Shobha N, Buchan AM, Hill MD; Canadian Alteplase for Stroke Effectiveness Study (CASES). Thrombolysis at 3-4.5 hours after acute ischemic stroke onset–evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Cerebrovasc Dis 2011;31:223–228.
   PubMed Web of Science ®Google Scholar
• Roth EJ, Heinemann AW, Lovell LL, Harvey RL, McGuire JR, Diaz S. Impairment and disability: their relation during stroke rehabilitation. Arch Phys Med Rehabil 1998;79:329–335.
   PubMed Web of Science ®Google Scholar
• Glymour MM, Berkman LF, Ertel KA, Fay ME, Glass TA, Furie KL. Lesion characteristics, NIH stroke scale, and functional recovery after stroke. Am J Phys Med Rehabil 2007;86:725–733.
   PubMed Web of Science ®Google Scholar
• Balu S. Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials: systematic literature review. Curr Med Res Opin 2009;25:1329–1341.
   PubMed Web of Science ®Google Scholar
• Quinn TJ, Langhorne P, Stott DJ. Barthel index for stroke trials: development, properties, and application. Stroke 2011;42:1146–1151.
   PubMed Web of Science ®Google Scholar
• Hsieh YW, Wang CH, Wu SC, Chen PC, Sheu CF, Hsieh CL. Establishing the minimal clinically important difference of the Barthel Index in stroke patients. Neurorehabil Neural Repair 2007;21:233–238.
   PubMed Web of Science ®Google Scholar
• Aggarwal NT, Schneider JA, Wilson RS, Beck TL, Evans DA, Carli CD. Characteristics of MR infarcts associated with dementia and cognitive function in the elderly. Neuroepidemiology 2012;38:41–47.
   PubMed Web of Science ®Google Scholar
• Ferguson C. Use of thrombolysis in acute ischaemic stroke. Emergency Medicine Journal. 2010;27:245.
   Web of Science ®Google Scholar
• Bruno A, Switzer JA, Durkalski VL, Nichols FT. Is a prestroke modified Rankin Scale sensible? Int J Stroke 2011;6:414–415.
   PubMed Web of Science ®Google Scholar
• Quinn TJ, Dawson J, Walters MR, Lees KR. Exploring the reliability of the modified rankin scale. Stroke 2009;40:762–766.
   PubMed Web of Science ®Google Scholar
• Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke 2009;40:3393–3395.
   PubMed Web of Science ®Google Scholar
• Saver JL. Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices. Stroke 2011;42:2356–2362.
   PubMed Web of Science ®Google Scholar
• Meyer M, Murie-Fernandez M, Hall R, Liu Y, Fang J, Salter K, Foley N, Teasell R. Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: a multivariable approach. Int J Stroke 2012;7:460–464.
   PubMed Web of Science ®Google Scholar
• Wagle J, Farner L, Flekkøy K, Bruun Wyller T, Sandvik L, Fure B, Stensrød B, Engedal K. Early post-stroke cognition in stroke rehabilitation patients predicts functional outcome at 13 months. Dement Geriatr Cogn Disord 2011;31:379–387.
   PubMed Web of Science ®Google Scholar
• Gadidi V, Katz-Leurer M, Carmeli E, Bornstein NM. Long-term outcome poststroke: predictors of activity limitation and participation restriction. Arch Phys Med Rehabil 2011;92:1802–1808.
   PubMed Web of Science ®Google Scholar
• Gunaydin R, Karatepe AG, Kaya T, Ulutas O. Determinants of quality of life (QoL) in elderly stroke patients: a short-term follow-up study. Arch Gerontol Geriatr 2011;53:19–23.
   PubMed Web of Science ®Google Scholar
• Haley WE, Roth DL, Kissela B, Perkins M, Howard G. Quality of life after stroke: a prospective longitudinal study. Qual Life Res 2011;20:799–806.
   PubMed Web of Science ®Google Scholar
• Leach MJ, Gall SL, Dewey HM, Macdonell RA, Thrift AG. Factors associated with quality of life in 7-year survivors of stroke. J Neurol Neurosurg Psychiatr 2011;82:1365–1371.
   PubMed Web of Science ®Google Scholar
• Boosman H, Schepers VP, Post MW, Visser-Meily JM. Social activity contributes independently to life satisfaction three years post stroke. Clin Rehabil 2011;25:460–467.
   PubMed Web of Science ®Google Scholar
• Graven C, Brock K, Hill K, Joubert L. Are the rehabilitation and/or care co-ordination interventions delivered in the community effective in reducing depression, facilitating participation and improving quality of life after stroke? Disability and Rehabilitation 2011;33:1501–1520.
   PubMed Web of Science ®Google Scholar
• Derex L, Nighoghossian N. Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients. Nat Rev Neurol 2009;5:506–511.
   PubMed Web of Science ®Google Scholar
• Kugler C, Altenhöner T, Lochner P, Ferbert A; Hessian Stroke Data Bank Study Group ASH. Does age influence early recovery from ischemic stroke? A study from the Hessian Stroke Data Bank. J Neurol 2003;250:676–681.
   PubMed Web of Science ®Google Scholar
• Delgado MG, Michel P, Naves M, Maeder P, Reichhart M, Wintermark M, Bogousslavsky J. Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population. J Neurol Neurosurg Psychiatr 2010;81:282–285.
   PubMed Web of Science ®Google Scholar
• Bodenant M, Leys D, Debette S, Cordonnier C, Dumont F, Hénon H, Girot M, et al. Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours. Cerebrovasc Dis 2010;30:148–156.
   PubMed Web of Science ®Google Scholar
• Hemmen TM, Rapp KS, Emond JA, Raman R, Lyden PD. Analysis of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study III patient selection criteria. J Stroke Cerebrovasc Dis 2010;19:290–293.
   PubMed Web of Science ®Google Scholar
• Zhou XY, Wang SS, Collins ML, Davis SM, Yan B. Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke. J Clin Neurosci 2010;17:988–992.
   PubMed Web of Science ®Google Scholar
• Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke--background and study protocol. 1985;16:885–890.
   Google Scholar
• Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480–484.
   PubMed Web of Science ®Google Scholar
• Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. Stroke 2000;31:1429–1438.
   PubMed Web of Science ®Google Scholar